Transfusion

Cover image for Vol. 57 Issue 5

May 2017

Volume 57, Issue 5

Pages C1–C1, 1099–1324

  1. Issue Information

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. Cover (page C1)

      Version of Record online: 20 APR 2017 | DOI: 10.1111/trf.13831

    2. Masthead and Table of Contents

      Version of Record online: 20 APR 2017 | DOI: 10.1111/trf.13830

  2. EDITORIAL

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
  3. TRANSFUSION MEDICINE ILLUSTRATED

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
  4. CLINICAL RESEARCH FOCUS

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
  5. HOW DO I…?

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. How do i participate in T-cell immunotherapy? (pages 1115–1121)

      Megan M. Suhoski Davis, David H. McKenna and Philip J. Norris

      Version of Record online: 5 APR 2017 | DOI: 10.1111/trf.14098

  6. DONOR INFECTIOUS DISEASE TESTING

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure (pages 1122–1131)

      Carl McDonald, Jennifer Allen, Susan Brailsford, Anjana Roy, Joanne Ball, Richard Moule, Mariza Vasconcelos, Rachael Morrison and Tyrone Pitt

      Version of Record online: 20 APR 2017 | DOI: 10.1111/trf.14085

  7. HEMAPHERESIS

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. Autologous lymphapheresis for the production of chimeric antigen receptor T cells (pages 1133–1141)

      Elizabeth S. Allen, David F. Stroncek, Jiaqiang Ren, Anne F. Eder, Kamille A. West, Terry J. Fry, Daniel W. Lee, Crystal L. Mackall and Cathy Conry-Cantilena

      Version of Record online: 24 FEB 2017 | DOI: 10.1111/trf.14003

    2. Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection (pages 1142–1151)

      Gagan Mathur, Sarah L. Mott, Laura Collins, Gail A. Nelson, C. Michael Knudson and Annette J. Schlueter

      Version of Record online: 1 FEB 2017 | DOI: 10.1111/trf.14022

    3. Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura (pages 1152–1162)

      Tanja Falter, Veronique Schmitt, Stephanie Herold, Veronika Weyer, Charis von Auer, Stefanie Wagner, Gudrun Hefner, Manfred Beutel, Karl Lackner, Bernhard Lämmle and Inge Scharrer

      Version of Record online: 24 MAR 2017 | DOI: 10.1111/trf.14060

  8. BLOOD MANAGEMENT

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. Single-unit transfusions and hemoglobin trigger: relative impact on red cell utilization (pages 1163–1170)

      William W. Yang, Rajiv N. Thakkar, Eric A. Gehrie, Weiyun Chen and Steven M. Frank

      Version of Record online: 5 FEB 2017 | DOI: 10.1111/trf.14000

  9. BLOOD COMPONENTS

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies (pages 1171–1183)

      Paolo Rebulla, Stefania Vaglio, Francesco Beccaria, Maurizio Bonfichi, Angelo Carella, Federico Chiurazzi, Serelina Coluzzi, Agostino Cortelezzi, Giorgio Gandini, Gabriella Girelli, Maria Graf, Paola Isernia, Giuseppe Marano, Maurizio Marconi, Rachele Montemezzi, Barbara Olivero, Marianna Rinaldi, Laura Salvaneschi, Nicola Scarpato, Paolo Strada, Silvano Milani and Giuliano Grazzini

      Version of Record online: 24 FEB 2017 | DOI: 10.1111/trf.14042

    2. You have full text access to this OnlineOpen article
      Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration (pages 1184–1191)

      Thomas Nowak, Birgit Popp, Albrecht Gröner, Wolfram Schäfer, Uwe Kalina, Karlheinz Enssle and Nathan J. Roth

      Version of Record online: 12 FEB 2017 | DOI: 10.1111/trf.14010

    3. Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols (pages 1208–1217)

      Ahmad F. Arbaeen, Peter Schubert, Katherine Serrano, Cedric J. Carter, Brankica Culibrk and Dana V. Devine

      Version of Record online: 24 FEB 2017 | DOI: 10.1111/trf.14043

    4. Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage (pages 1218–1225)

      Jose A. Cancelas, Sherrill J. Slichter, Neeta Rugg, P. Gayle Pratt, Shawnagay Nestheide, Jill Corson, Esther Pellham, Marty Huntington and Raymond P. Goodrich

      Version of Record online: 31 MAR 2017 | DOI: 10.1111/trf.14084

  10. BLOOD DONORS AND BLOOD COLLECTION

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. Trends in US minority red blood cell unit donations (pages 1226–1234)

      Mark H. Yazer, Meghan Delaney, Marc Germain, Matthew S. Karafin, Merlyn Sayers, Ralph Vassallo, Alyssa Ziman, Beth Shaz and on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

      Version of Record online: 16 FEB 2017 | DOI: 10.1111/trf.14039

    2. Phylogenetic evidence for underreporting of male-to-male sex among human immunodeficiency virus–infected donors in the Netherlands and Flanders (pages 1235–1247)

      Thijs J. van de Laar, Daniela Bezemer, Kristel van Laethem, Giovani Vandewalle, Annie de Smet, Eric van Wijngaerden, Eric C. Claas, Ard I. van Sighem, Anne-Mieke Vandamme, Veerle Compernolle and Hans L. Zaaijer

      Version of Record online: 4 APR 2017 | DOI: 10.1111/trf.14097

  11. BLOOD GROUP GENOMICS

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. First description of a D-CE-D hybrid gene on a weak D Type 2 molecular background (pages 1248–1253)

      Thomas Granier, Jacques Chiaroni, Pascal Bailly and Monique Silvy

      Version of Record online: 5 FEB 2017 | DOI: 10.1111/trf.14023

  12. TRANSFUSION PRACTICE

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. A national review of the clinical use of group O D– red blood cell units (pages 1254–1261)

      Rena Hirani, Janet Wong, Perfecto Diaz, Phillip Mondy, Chris Hogan, Peta M. Dennington, Joanne Pink and David O. Irving

      Version of Record online: 1 FEB 2017 | DOI: 10.1111/trf.14012

  13. IMMUNE HEMATOLOGIC DISEASES

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. A rare, potentially life-threatening presentation of passenger lymphocyte syndrome (pages 1262–1266)

      Thomas J. Gniadek, Andrea M. McGonigle, R. Sue Shirey, Patricia A. Brunker, Michael Streiff, Benjamin Philosophe, Evan M. Bloch, Paul M. Ness and Karen E. King

      Version of Record online: 28 MAR 2017 | DOI: 10.1111/trf.14055

    2. Human platelet antigen (HPA)-specific immunoglobulin M antibodies in neonatal alloimmune thrombocytopenia can inhibit the binding of HPA-specific immunoglobulin G antibodies (pages 1267–1271)

      Matthew Hopkins, Geoff Lucas, Anthony Calvert, Nina Bendukidze, Frances Green, Krishna Kotecha and Anthony Poles

      Version of Record online: 24 FEB 2017 | DOI: 10.1111/trf.14047

    3. Human platelet antigen antibody induction in uncomplicated pregnancy is associated with HLA sensitization (pages 1272–1279)

      Viktoria S.A. Reiher, Gideon Hönger, Laura Infanti, Jakob R. Passweg, Irene Hösli, Beat M. Frey, Christoph Gassner, Stefan Meyer, Andreas S. Buser, Andreas Holbro and Stefan Schaub

      Version of Record online: 10 MAR 2017 | DOI: 10.1111/trf.14053

  14. EDUCATION AND ADMINISTRATION

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. An international survey on the role of the hospital transfusion committee (pages 1280–1287)

      Mark H. Yazer, Miguel Lozano, Mark Fung, Jose Kutner, Michael F. Murphy, Torunn Oveland Apelseth, Ryszard Pogłód, Kathleen Selleng, Alan Tinmouth, Silvano Wendel, Vered Yahalom and on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

      Version of Record online: 24 FEB 2017 | DOI: 10.1111/trf.14033

  15. IMMUNOHEMATOLOGY

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. Patient factors associated with unidentified reactivity in solid-phase and polyethylene glycol antibody detection methods (pages 1288–1293)

      Nichole M. Miller, Susan T. Johnson, Erica Carpenter, Christine A. Naczek and Matthew S. Karafin

      Version of Record online: 14 MAR 2017 | DOI: 10.1111/trf.14079

  16. TRANSFUSION COMPLICATIONS

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. Determining the rate of underrecognition of West Nile virus neurologic disease in the province of Quebec in 2012 (pages 1294–1298)

      Gilles Delage, Sophie Dubuc, Yves Grégoire, Anne-Marie Lowe, France Bernier and Marc Germain

      Version of Record online: 16 MAR 2017 | DOI: 10.1111/trf.14081

    2. Septic transfusion case caused by a platelet pool with visible clotting due to contamination with Staphylococcus aureus (pages 1299–1303)

      Maria Loza-Correa, Yuntong Kou, Mariam Taha, Miloslav Kalab, Jennifer Ronholm, Patrick M. Schlievert, Michael P. Cahill, Robert Skeate, Christine Cserti-Gazdewich and Sandra Ramirez-Arcos

      Version of Record online: 16 FEB 2017 | DOI: 10.1111/trf.14049

    3. Red blood cell transfusions can induce proinflammatory cytokines in preterm infants (pages 1304–1310)

      Carlo Dani, Chiara Poggi, Elena Gozzini, Valentina Leonardi, Alice Sereni, Rosanna Abbate and Anna Maria Gori

      Version of Record online: 11 MAR 2017 | DOI: 10.1111/trf.14080

    4. Prioritizing of bacterial infections transmitted through substances of human origin in Europe (pages 1311–1317)

      Dragoslav Domanović, Alessandro Cassini, Isabelle Bekeredjian-Ding, Arlinke Bokhorst, Martijn Bouwknegt, Giuseppina Facco, George Galea, Paolo Grossi, Ramadan Jashari, Christoph Jungbauer, Jan Marcelis, Ioana Raluca-Siska, Inger Andersson-Vonrosen and Jonathan E. Suk

      Version of Record online: 24 FEB 2017 | DOI: 10.1111/trf.14036

  17. REPORT OF NEW ALLELES OR ANTIGENS

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
  18. LETTERS TO THE EDITOR

    1. Top of page
    2. Issue Information
    3. EDITORIAL
    4. TRANSFUSION MEDICINE ILLUSTRATED
    5. CLINICAL RESEARCH FOCUS
    6. HOW DO I…?
    7. DONOR INFECTIOUS DISEASE TESTING
    8. HEMAPHERESIS
    9. BLOOD MANAGEMENT
    10. BLOOD COMPONENTS
    11. BLOOD DONORS AND BLOOD COLLECTION
    12. BLOOD GROUP GENOMICS
    13. TRANSFUSION PRACTICE
    14. IMMUNE HEMATOLOGIC DISEASES
    15. EDUCATION AND ADMINISTRATION
    16. IMMUNOHEMATOLOGY
    17. TRANSFUSION COMPLICATIONS
    18. REPORT OF NEW ALLELES OR ANTIGENS
    19. LETTERS TO THE EDITOR
    1. Assuring hospital supply of fresh red blood cells for critically ill patients (pages 1320–1321)

      Tiffany M. Graham, Daniel B. Peavey, Tammy Gray, Rakesh P. Patel, Henry E. Wang, Jean-Francois Pittet, Jeffrey D. Kerby and Marisa B. Marques

      Version of Record online: 20 APR 2017 | DOI: 10.1111/trf.14058

SEARCH

SEARCH BY CITATION